Keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.
UPC: | gsk-0000022 |
---|---|
رمز SKU للبائع: | gsk-0000022 |
حالة: | New |
التوفر: | في الأوراق المالية |
أقل كمية ممكن طلبها: | 1 |
التاريخ المدرج لأول مرة على Zandaux: | Sep 10, 2024 |
Keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.
KEY FEATURES:
Keppra is effective in treating both focal seizures with or without secondary generalization.
It can also be used to treat generalized tonic-clonic seizures.
Keppra is effective in treating myoclonic seizures, which are sudden, brief muscle jerks.
لم يتم تقديم تعليقات
عضو منذ: منذ 5 أشهر
نحن على بعد خطوة واحدة فقط! الرجاء تسجيل الدخول لبدء المحادثة. تسجيل الدخول